Lebwohl David — SEC Form 4 filings

SEC reporting owner CIK 1810882. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-05 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Intellia Therapeutics, Inc. (NTLA)EVP, Chief Medical Officer62 legs · 21,460 sh · $226,0318

Form 4 filings — Lebwohl David

FiledFormIssuerReported transactionsSource
2026-03-034Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 9,943 @ $0 · Grant/award (A): 14,204 (derivative) @ $0EDGAR
2026-01-074Intellia Therapeutics, Inc. (NTLA)Sale (S): 11,903 @ $9.21EDGAR
2025-03-044Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 43,200 @ $0 · Grant/award (A): 61,714 (derivative) @ $0EDGAR
2025-01-074Intellia Therapeutics, Inc. (NTLA)Sale (S): 9,557 @ $12.18EDGAR
2025-01-034Intellia Therapeutics, Inc. (NTLA)Option exercise (M): 3,189 · Option exercise (M): 3,189 (derivative) @ $0EDGAR
2024-03-054Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 38,701 @ $0 · Grant/award (A): 55,855 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1810882 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →